Literature DB >> 10644050

Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical.

A Chattopadhyay1, T D Choudhury, D Bandyopadhyay, A G Datta.   

Abstract

Treatment of red blood cells with the copper (II) ascorbate system causes increased lipid peroxidation, increased membrane microviscosity, and phospholipid translocation with a concurrent decrease in cytosolic catalase and glutathione peroxidase activities. All these changes are prevented if the cells are treated with erythropoietin prior to the exposure to copper (II) ascorbate. The present investigation further indicates that the oxidative damage brought about by copper (II) ascorbate is due to generation of hydroxyl radical and that erythropoietin plays a unique role in protecting the membrane from oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644050     DOI: 10.1016/s0006-2952(99)00277-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  37 in total

1.  Oxidant induced injury of erythrocyte-role of green tea leaf and ascorbic acid.

Authors:  Sabyasachi Biswas; Jharna Bhattacharyya; Asoke G Dutta
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

2.  Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin.

Authors:  Robin K Ohls; Daniel C Cannon; John Phillips; Arvind Caprihan; Shrena Patel; Sarah Winter; Michael Steffen; Ronald A Yeo; Richard Campbell; Susan Wiedmeier; Shawna Baker; Sean Gonzales; Jean Lowe
Journal:  Pediatrics       Date:  2016-02-15       Impact factor: 7.124

3.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

Review 4.  Pharmacologic neuroprotective strategies in neonatal brain injury.

Authors:  Sandra E Juul; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

5.  Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.

Authors:  Robin K Ohls; Beena D Kamath-Rayne; Robert D Christensen; Susan E Wiedmeier; Adam Rosenberg; Janell Fuller; Conra Backstrom Lacy; Mahshid Roohi; Diane K Lambert; Jill J Burnett; Barbara Pruckler; Hannah Peceny; Daniel C Cannon; Jean R Lowe
Journal:  Pediatrics       Date:  2014-05-12       Impact factor: 7.124

6.  Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats.

Authors:  Ensari Guneli; Zahide Cavdar; Huray Islekel; Sulen Sarioglu; Serhat Erbayraktar; Muge Kiray; Selman Sokmen; Osman Yilmaz; Necati Gokmen
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

7.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

Review 8.  Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems.

Authors:  Jian-Ming Lü; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

Review 9.  Erythropoietin (epoetin) as a protective factor for the brain.

Authors:  Samit Malhotra; Sheetal Nijhawan; Daniel M Rosenbaum
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.